Literature DB >> 32312861

Exercise intolerance in chronic thromboembolic pulmonary hypertension after pulmonary angioplasty.

Hanako Kikuchi1, Ayumi Goda2, Kaori Takeuchi1, Takumi Inami1, Takashi Kohno1, Konomi Sakata1, Kyoko Soejima1, Toru Satoh1.   

Abstract

INTRODUCTION: Exercise pulmonary hypertension is common in patients with chronic thromboembolic pulmonary hypertension (CTEPH) who experience shortness of breath during exercise and reduced exercise capacity despite normalised pulmonary arterial pressure (PAP) at rest; however, the relationship between exercise pulmonary hypertension and exercise capacity remains unclear. Here we aimed to determine whether exercise pulmonary hypertension is related to exercise capacity and ventilatory efficiency in CTEPH patients with normalised resting haemodynamics after pulmonary balloon angioplasty (BPA). PATIENTS AND METHODS: In total, 249 patients with CTEPH treated with BPA (mean±sd age 63±14 years; male:female 62:187) with normal mean PAP (mPAP) (<25 mmHg) and pulmonary arterial wedge pressure (≤15 mmHg) at rest underwent cardiopulmonary exercise testing with right heart catheterisation. mPAP-cardiac output (CO) during exercise was plotted using multipoint plots. Exercise pulmonary hypertension was defined by a mPAP-CO slope >3.0.
RESULTS: At rest, pulmonary vascular resistance was significantly higher in the exercise pulmonary hypertension group (n=116) than in the non-exercise pulmonary hypertension group (n=133). Lower peak oxygen consumption (13.5±3.8 versus 16.6±4.7 mL·min-1·kg-1; p<0.001) was observed in the former group. The mPAP-CO slope was negatively correlated with peak oxygen consumption (r= -0.45, p<0.001) and positively correlated with the minute ventilation versus carbon dioxide output slope (r=0.39, p<0.001).
CONCLUSIONS: Impaired exercise capacity and ventilatory efficiency were observed in patients with CTEPH who had normalised PAP at rest but exercise pulmonary hypertension.
Copyright ©ERS 2020.

Entities:  

Mesh:

Year:  2020        PMID: 32312861     DOI: 10.1183/13993003.01982-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  Diffusing Capacity for Carbon Monoxide Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Xin Li; Yi Zhang; Qin Luo; Qing Zhao; Qixian Zeng; Tao Yang; Qi Jin; Lu Yan; Anqi Duan; Jiaran Liu; Chenhong An; Xiuping Ma; Changming Xiong; Zhihui Zhao; Zhihong Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-02

2.  Cardiopulmonary exercise testing and pulmonary function testing for predicting the severity of CTEPH.

Authors:  Hanqing Zhu; Xingxing Sun; Yuan Cao; Bigyan Pudasaini; Wenlan Yang; Jinming Liu; Jian Guo
Journal:  BMC Pulm Med       Date:  2021-10-18       Impact factor: 3.317

3.  EmPHasis-10 Health-Related Quality of Life and Exercise Capacity in Chronic Thromboembolic Pulmonary Hypertension After Balloon Angioplasty.

Authors:  Hayato Sakamoto; Ayumi Goda; Kazuki Tobita; Kaori Takeuchi; Hanako Kikuchi; Takumi Inami; Yuichi Tamura; Takashi Kohno; Shin Yamada; Kyoko Soejima; Toru Satoh
Journal:  J Am Heart Assoc       Date:  2022-09-03       Impact factor: 6.106

4.  Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension.

Authors:  Keisuke Miwa; Yu Taniguchi; Hiroyuki Fujii; Yoichiro Matsuoka; Hiroyuki Onishi; Kenichi Yanaka; Yu Izawa; Yasunori Tsuboi; Atsushi Kono; Noriaki Emoto; Kenichi Hirata
Journal:  Life (Basel)       Date:  2022-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.